Report cover image

Global Castrate Resistant Prostate Cancer Therapeutics Supply, Demand and Key Producers, 2026-2032

Publisher GlobalInfoResearch
Published Jan 15, 2026
Length 109 Pages
SKU # GFSH20744868

Description

The global Castrate Resistant Prostate Cancer Therapeutics market size is expected to reach $ 43750 million by 2032, rising at a market growth of 11.0% CAGR during the forecast period (2026-2032).

Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC.

The treatment of castration-resistant prostate cancer is to use various methods to treat the recurrence and metastasis of cancer cells or to control hormones.

Global key players of castrate resistant prostate cancer therapeutics include Pfizer, Johnson & Johnson, AstraZeneca, Bayer, Jiangsu Hengrui Pharmaceuticals etc. The top five players hold a share over 70%. North America is the largest market, has a share over 40%, followed by Europe, and Asia-Pacific, with share 28% and 22%, separately.

This report studies the global Castrate Resistant Prostate Cancer Therapeutics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Castrate Resistant Prostate Cancer Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Castrate Resistant Prostate Cancer Therapeutics that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Castrate Resistant Prostate Cancer Therapeutics total market, 2021-2032, (USD Million)

Global Castrate Resistant Prostate Cancer Therapeutics total market by region & country, CAGR, 2021-2032, (USD Million)

U.S. VS China: Castrate Resistant Prostate Cancer Therapeutics total market, key domestic companies, and share, (USD Million)

Global Castrate Resistant Prostate Cancer Therapeutics revenue by player, revenue and market share 2021-2026, (USD Million)

Global Castrate Resistant Prostate Cancer Therapeutics total market by Type, CAGR, 2021-2032, (USD Million)

Global Castrate Resistant Prostate Cancer Therapeutics total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Castrate Resistant Prostate Cancer Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer/Astellas (Xtandi), Johnson & Johnson, AstraZeneca/Merck (Lynparza), Bayer, Jiangsu Hengrui Pharmaceuticals, CTTQ, Sanofi, Hansoh, Clovis Oncology, Zhendong Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Castrate Resistant Prostate Cancer Therapeutics market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Castrate Resistant Prostate Cancer Therapeutics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Castrate Resistant Prostate Cancer Therapeutics Market, Segmentation by Type:
Hormonal Therapy
Chemotherapy
Others

Global Castrate Resistant Prostate Cancer Therapeutics Market, Segmentation by Application:
Hospital
Specialty Clinic
Others

Companies Profiled:
Pfizer/Astellas (Xtandi)
Johnson & Johnson
AstraZeneca/Merck (Lynparza)
Bayer
Jiangsu Hengrui Pharmaceuticals
CTTQ
Sanofi
Hansoh
Clovis Oncology
Zhendong Pharmaceutical

Key Questions Answered

1. How big is the global Castrate Resistant Prostate Cancer Therapeutics market?

2. What is the demand of the global Castrate Resistant Prostate Cancer Therapeutics market?

3. What is the year over year growth of the global Castrate Resistant Prostate Cancer Therapeutics market?

4. What is the total value of the global Castrate Resistant Prostate Cancer Therapeutics market?

5. Who are the Major Players in the global Castrate Resistant Prostate Cancer Therapeutics market?

6. What are the growth factors driving the market demand?

Table of Contents

109 Pages
1 Supply Summary
2 Demand Summary
3 World Castrate Resistant Prostate Cancer Therapeutics Companies Competitive Analysis
4 United States VS China VS Rest of World (by Headquarter Location)
5 Market Analysis by Type
6 Market Analysis by Application
7 Company Profiles
8 Industry Chain Analysis
9 Research Findings and Conclusion
10 Appendix

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us